| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Guido J Neels is Director at ELUT, with reported holdings spanning 4 companies. Guido J Neels's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.0M at current prices.
Our model assigns Guido J Neels a below-average insider score of 48/100, based on 5 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -2.5%.
Guido J Neels's largest disclosed position is in AXGN as Director, worth about $4.5M. The AXGN filings lean toward selling, a net 1,144,073 shares.
Guido J Neels has 34 Form 4 filings on record from December 2015 to June 2026, across 4 companies: Director at Elutia (ELUT), 2025–2026; Director at TELA Bio (TELA), 2026; Director at Bioventus (BVS), 2021–2026, and 1 more.
The 50 reported transactions were 26 option or other derivative awards, 14 option exercises, 4 stock awards and 4 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $114K and 2 sales worth about $22.7M.
The largest open-market purchase was 10,000 shares of AXGN at an average $6.11 on August 16, 2023, about $61K. Twelve months later AXGN was up 95%.
The largest open-market sale was 1,150,000 shares of AXGN at an average $19.74 on November 20, 2017, about $22.7M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | ELUT Elutia Inc. | Director | Buy | 20,000 | $1.04 | $20,800.00 | +20.3% | -2.9% | - | |
| Jan 29, 2026 | ELUT Elutia Inc. | Director | Buy | 30,000 | $1.06 | $31,800.00 | +43.6% | -4.8% | - | |
| Jun 9, 2025 | AXGN Axogen, Inc. | Director | Sell | 4,073 | $10.61 | $43,214.53 | -4.5% | +54.1% | +311.8% | |
| Aug 16, 2023 | AXGN Axogen, Inc. | Director | Buy | 10,000 | $6.11 | $61,100.00 | +17.2% | -0.5% | +95.0% | |
| Nov 20, 2017 | AXGN Axogen, Inc. | Director | Sell | 1,150,000 | $19.74 | $22,701,000.00 | -25.4% | - | - |